These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7046275)

  • 1. [Leukocyte adherence inhibition test (LAI): instrumentation, procedure and possibilities for use].
    Lehmitz R; Grap H; Schulze H; Ziegler K
    Z Med Lab Diagn; 1982 Jan; 23(1):49-54. PubMed ID: 7046275
    [No Abstract]   [Full Text] [Related]  

  • 2. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
    Kharkevich DD; Tabagari DZ; Savinov AIu
    Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage adherence inhibition assay: measurements of adherent cells by the TV image analysis system Densitron.
    Schimke R; Hess J; Ambrosius H
    Allerg Immunol (Leipz); 1981; 27(4):227-34. PubMed ID: 6462044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucocyte migration inhibition test in post-antirabies vaccinal encephalitis (a preliminary communication).
    Shivanand PG; Rao PV; Venkatesh A; Bhat KR; Subbnanayya K; Elias A; Rao KN
    J Postgrad Med; 1981 Oct; 27(4):222-5. PubMed ID: 6121912
    [No Abstract]   [Full Text] [Related]  

  • 6. [Leukocyte adherence inhibition test (LAI)].
    Matsumoto Y
    Rinsho Byori; 1981 Apr; (Suppl 45):250-64. PubMed ID: 7026839
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the haemocytometer and tube modifications of the leucocyte adherence inhibition assay.
    Holán V; Schimke R; Ambrosius H; Hasek M
    Folia Biol (Praha); 1981; 27(1):66-75. PubMed ID: 6162681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
    Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
    Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukocyte adherence inhibition (LAI) test in patients with chronic liver diseases].
    Matsumoto Y; Ishihara J; Yamamoto M
    Rinsho Byori; 1985 Apr; 33(4):421-5. PubMed ID: 3900488
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some methodical aspects of the leukocyte adherence inhibition test (LAI)].
    Teuber S; Storch H
    Z Med Lab Diagn; 1986; 27(3):169-73. PubMed ID: 3524045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
    Mounielou PM; Clemente F; Estival A; Ribet A
    Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
    Horváth M; Tóth L; Tóth J; Fekete B
    Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodical standardization for the clinical use of the LAI test].
    Jandová A; Heyberger K
    Sb Lek; 1980; 82(11-12):382-4. PubMed ID: 7008173
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tumor immunity and the LAI test].
    Hasek M
    Cesk Dermatol; 1980 Aug; 55(4):263-5. PubMed ID: 6996845
    [No Abstract]   [Full Text] [Related]  

  • 16. Tube LAI assay in diagnosis and monitoring of a cancer disease.
    Hasek M; Holán V; Kousalová M
    Biomedicine; 1981 Dec; 35(7-8):207-8. PubMed ID: 7049257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of immunological studies in patients with maxillofacial malignancies. 1. Leukocyte adherence inhibition tests (LAI)].
    Teuber S; Storch H; Gitt HA
    Stomatol DDR; 1984 May; 34(5):266-72. PubMed ID: 6382696
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO; Restbergs V
    Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study about the use of LAI test and MI test in immunodiagnostics of gynecological tumours (author's transl)].
    Jandová A; Svec M; Heyberger K; Laurová L; Novotná J; Roubal J; Trnka V; Vancurik J
    Cesk Gynekol; 1979 Feb; 44(1):44-50. PubMed ID: 371825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possible use of the LAI test in clinical oncology].
    Procházka J; Hasek M; Deyl Z; Sobĕslavský C; Sochorová L
    Cas Lek Cesk; 1983 Dec; 122(49):1526-30. PubMed ID: 6360376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.